$0.3021
-0.0038-1.24%
Last update: Oct 16, 12:00 PM
MEDICENNA THERA CORP by Medicenna Therapeutics Corp. (MDNAF) Stock Price, Quote, News & History
MDNAFOTCQB
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of MEDICENNA THERA CORP by Medicenna Therapeutics Corp. (OTCQB:MDNAF) through any online brokerage.
There are no as such competitors for MEDICENNA THERA CORP by Medicenna Therapeutics Corp..
There is no analysis for MEDICENNA THERA CORP by Medicenna Therapeutics Corp. to provide a consensus price target.
The stock price for MEDICENNA THERA CORP by Medicenna Therapeutics Corp. (OTCQB: MDNAF) is $0.30215 last updated October 16, 2026 at 12:00 PM EDT.
There are no upcoming dividends for MEDICENNA THERA CORP by Medicenna Therapeutics Corp..
MEDICENNA THERA CORP by Medicenna Therapeutics Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for MEDICENNA THERA CORP by Medicenna Therapeutics Corp..
MEDICENNA THERA CORP by Medicenna Therapeutics Corp. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Medicenna Therapeutics Corp is the development and commercialization of IL-2, IL-4 and IL-13 Superkines and empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its platforms are Superkine, BISCUIT, TEMASK,...
